Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FY8BN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,523
Award facts
- Contract value 100% obligated
- $8,523.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,523.37 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on November 3, 2025, with a completion date of November 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a direct pharmaceutical procurement supporting federal healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems through the DLA's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract serves multiple federal customers including the Defense Health Agency and the U.S. Coast Guard, positioning AmerisourceBergen as a key strategic partner in the DLA's pharmaceutical prime vendor program infrastructure.
Quick answers
Who was awarded contract SPE2DR26FY8BN?
SPE2DR26FY8BN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FY8BN worth?
The government has obligated $8,523 on SPE2DR26FY8BN.
Is contract SPE2DR26FY8BN an order under another contract?
Yes. SPE2DR26FY8BN is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8BN competed?
The extent of competition for SPE2DR26FY8BN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award